REGULATORY mechanisms in bradykinin (BK) activated release of arachidonate (ARA) and synthesis of prostaglandin (PG) and platelet activating factor (PAF) were studied in bovine pulmonary artery endothelial cells (BPAEC). A role for GTP binding protein (G-protein) 
Introduction
The exposure of endothelial cells to bradykinin (BK), a nonapeptide with inflammatory as well as vasoactive functions, results in the activation of a number of early metabolic events as determined in a number of cell types. These events include a biphasic increase in cytosolic Ca2+,1-4 a transient membrane hyperpolarization, the activation of K + channels, 6 formation of diacylglycerol (DAG) and phosphatidic acid, 7 release of arachidonate (ARA) from phospholipid stores and synthesis of prostaglandin (PG) and platelet activating factor (PAF). Many of these events Cultures not treated with TPA 11 Cultures treated with 100 nM TPA production was determined at various concentrations of BK from 0.01 to 50 nM. In this case a maximum was reached between 0.5 and 2 nM BK.
The interaction of TPA with BK and GTP:S is illustrated in Fig. 11 Cells were treated as described in Fig. 9 . After the 10 min PMA incubation, cells were permeabilized with saponin (0.02 mg/ml) for 3 min and then medium containing 2 mg/ml BSA with or without BK (50 nM) or GTP,S (100 #M) was added. Fig. 9 by the TPA-augmented, BK-induced synthesis of PAF. In these experiments the synthesis of PAF was determined through the remodelling pathway which utilizes PLA2 to remove fatty acid from the sn-2 position of 1-O-alkyl-2-acyl-sn-glyceryl-3-phosphocholine and incorporates acetate into the lyso-PAF via lyso-PAF acetyl-CoA acetyltransferase (LPAT) to form the 1-O-alkyl-2-acetyl-snglyceryl-3-phosphocholine (PAF TPA also did not affect GTPS activation of release (Fig. 11) , suggesting that the two events represent separate paths to the activation of PEA 2. As we illustrated, BK does generate DAG (Fig.  10) , and thus may, under certain conditions, additionally activate the release of arachidonate through the action of protein kinase C.
